Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 1.00 |
| ▸ | PDE6D | O43924 | 3/20 | 0.82 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.82 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.82 |
| ▸ | TP53 | P04637 | 5/20 | 0.74 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.71 |
| ▸ | HTT | P42858 | 3/20 | 0.71 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | HPGD | P15428 | 2/20 | 0.71 |
| ▸ | DRD2 | P14416 | 1/20 | 0.66 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | CNR2 | P34972 | 1/20 | 0.64 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | GALR3 | O60755 | 1/20 | 0.64 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28261637 | 0.95 | ALDH1A1 (0.91) | ALDH1A1PDE6DALDH2ALDH3A1TP53 | |
| SCHEMBL229828 | 0.91 | ALDH1A1 (1.00) | ALDH1A1PDE6DALDH2ALDH3A1TP53 | |
| SCHEMBL28479510 | 0.88 | ALDH1A1 (0.79) | ALDH1A1PDE6DALDH2ALDH3A1TP53 | |
| SCHEMBL29411974 | 0.88 | ALDH1A1 (0.79) | ALDH1A1PDE6DALDH2ALDH3A1TP53 | |
| SCHEMBL29411970 | 0.88 | TP53 (0.89) | ALDH1A1PDE6DALDH2ALDH3A1TP53 | |
| SCHEMBL15568856 | 0.87 | ALDH1A1 (0.80) | ALDH1A1PDE6DALDH2ALDH3A1TP53 | |
| SCHEMBL15474496 | 0.87 | ALDH1A1 (0.80) | ALDH1A1PDE6DALDH2ALDH3A1TP53 | |
| SCHEMBL9006294 | 0.87 | ALDH1A1 (0.80) | ALDH1A1PDE6DALDH2ALDH3A1TP53 | |
| SCHEMBL15568179 | 0.85 | ALDH1A1 (0.78) | ALDH1A1PDE6DALDH2ALDH3A1TP53 | |
| SCHEMBL15569395 | 0.85 | ALDH1A1 (0.78) | ALDH1A1PDE6DALDH2ALDH3A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080058525-A1 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, LLC | 2008-03-06 | — | — | US | claimed |
| US-20040171817-A1 | Novel dye complexes and use thereof in imaging members and methods | ZINK HOLDINGS LLC | 2004-09-02 | — | — | US | claimed |
| WO-2022057930-A1 | BENZIMIDAZOLE COMPOUND HAVING ENDOTHELIAL LIPASE INHIBITION EFFECT, AND APPLICATION | 盐城师范学院 | 2022-03-24 | — | — | WO | disclosed |
| US-20080058525-A1 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | ZINK IMAGING, LLC | 2008-03-06 | — | — | US | disclosed |
| US-7282317-B2 | Dye complexes and use thereof in imaging members and methods | ZINK IMAGING, LLC (US) | 2007-10-16 | — | — | US | disclosed |
| US-20040171817-A1 | Novel dye complexes and use thereof in imaging members and methods | ZINK HOLDINGS LLC | 2004-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080058525-A1 | NOVEL DYE COMPLEXES AND USE THEREOF IN IMAGING MEMBERS AND METHODS | DBI, HSPE1, ABCB7 | ALDH1A1 2233/4885PDE6D 3929/4885ALDH2 454/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.